Search

Your search keyword '"Belfiglio, Maurizio"' showing total 151 results
Start Over Author "Belfiglio, Maurizio"
151 results on '"Belfiglio, Maurizio"'

3. Multicentric, Randomized Phase III Trial of Two Different Adjuvant Chemotherapy Regimens plus Three Versus Twelve Months of Trastuzumab in Patients with HER2-Positive Breast Cancer (Short-HER Trial; NCT00629278)

Author

Guarneri, Valentina, Frassoldati, Antonio, Bruzzi, Paolo, D'Amico, Roberto, Belfiglio, Maurizio, Molino, Annamaria, Bertetto, Oscar, Cascinu, Stefano, Cognetti, Francesco, Di Leo, Angelo, Pronzato, Paolo, Crinó, Lucio, Agostara, Biagio, and Conte, PierFranco

Published
2008
Full Text
View/download PDF

18. Role of organizational factors in poor blood pressure control in patients with type 2 diabetes: quality of care and outcomes in type 2 diabetes

Author

Pellegrini, Fabio, Belfiglio, Maurizio, Berardis, Giorgia de, Franciosi, Monica, Nardo, Barbara di, Greenfield, Sheldon, Kaplan, Sherrie H., Sacco, Michele, Tognoni, Gianni, Valentini, Miriam, Corrado, Donatella, D'Ettorre, Antonio, and Nicolucci, Antonio

Subjects
Type 2 diabetes -- Care and treatment, Hypertension -- Care and treatment, Cookery for hypertensives, Health
Published
2003

21. The Relationship Between Physicians' Self-Reported Target Fasting Blood Glucose Levels and Metabolic Control in Type 2 Diabetes: The QuED Study Group-Quality of care and outcomes in type 2 diabetes

Author

Belfiglio, Maurizio, De Berardis, Giorgia, Franciosi, Monica, Cavaliere, Donatella, Di Nardo, Barbara, Greenfield, Sheldon, Kaplan, Sherrie H., Pellegrini, Fabio, Sacco, Michele, Tognoni, Gianni, Valentini, Miriam, Nicolucci, Antonio, Caimi, Vittorio, Capani, Fabio, Corsi, Andrea, Vedova, Roberto Della, Benedetti, Massimo Massi, Nicolucci, Antonio, Taboga, Claudio, Tombesi, Massimo, and Vespasiani, Giacomo

Published
2001

22. Erectile dysfunction and quality of life in type 2 diabetic patients: A serious problem too often overlooked. (Epidemiology/Health services/Psychosocial Research)

Author

Berardis, Giorgia De, Franciosi, Monica, Belfiglio, Maurizio, Nardo, Barbara Di, Greenfield, Sheldon, Kaplan, Sherrie H., Pellegrini, Fabio, Sacco, Michele, Tognoni, Gianni, Valentini, Miriam, and Nicolucci, Antonio

Subjects
Impotence -- Psychological aspects -- Complications and side effects, Men -- Health aspects, Diabetes -- Research, Type 2 diabetes -- Complications and side effects, Diabetics -- Psychological aspects -- Surveys, Quality of life -- Surveys -- Psychological aspects -- Health aspects, Health, Psychological aspects, Complications and side effects, Surveys, Health aspects
Abstract

GIORGIA DE BERARDIS (1) MONICA FRANCIOSI (1) MAURIZIO BELFIGLIO (1) BARBARA DI NARDO (1) SHELDON GREENFIELD (2) SHERRIE H. KAPLAN (2) FABIO PELLEGRINI (1) MICHELE SACCO (1) GIANNI TOGNONI (1) [...]

Published
2002

23. OUTCOMES RESEARCH IN ONCOLOGY: AN ITALIAN EXPERIENCE

Author

Belfiglio, Maurizio, Valentini, Miriam, Nicolucci, Antonio, Tognoni, Gianni, Labianca, Roberto, Tondini, Carlo, Imberti, Gianlorenzo, Grassi, Anna, Delaini, Federica, and Barbui, Tiziano

Published
2001

30. The Impact of Physicians' Attitudes on Metabolic Control in Type 2 Diabetes

Author

NICOLUCCI, ANTONIO, BELFIGLIO, MAURIZIO, DE BERARDIS, GIORGIA, and FRANCIOSI, MONICA

Subjects
Type 2 diabetes -- Care and treatment, Physicians -- Beliefs, opinions and attitudes, Blood sugar monitoring -- Methods, Glucose metabolism -- Physiological aspects, Health
Abstract

In the framework of a nation-wide outcomes research program on type 2 diabetes, we investigate attitudes of Italian physicians relative to intensive metabolic control and evaluated their relationship with the [...]

Published
2000

31. Real Time Assessment of Determinants of Transferability of Research Results: the Case of the UK Prospective Diabetes Study

Author

NICOLUCCI, ANTONIO, BELFIGLIO, MAURIZIO, GIORGIA, DE BERARDIS, MONICA, FRANCIOSI, NICOLA, SCORPIGLIONE, and IMBARO, S. MARIA

Subjects
Diabetes -- Research, Health
Abstract

In the framework of the QuED Project, a nationwide initiative aimed at assessing the relationship between quality of care and outcome in type 2 diabetes, we conducted a survey to [...]

Published
1999

35. Employment status and education level are associated with survival in skin melanoma.

Author

Mandalà, Mario, primary, Imberti, Gian lorenzo, additional, Piazzalunga, Darrio, additional, Belfiglio, Maurizio, additional, Lucisano, Giuseppe, additional, Labianca, Roberto, additional, Marchesi, Lorenzo, additional, Merelli, Barbara, additional, Robone, Silvana, additional, Poletti, Paola, additional, Milesi, Laura, additional, and Tondini, Carlo, additional

Published
2011
Full Text
View/download PDF

37. Research Trends for Early Cancer Biomarker Detection in Italy: An Integrated Program in Oncology (PIO) Survey

Author

Verderio, Paolo, primary, Mangia, Anita, additional, Orlando, Claudio, additional, Belfiglio, Maurizio, additional, Marchetti, Antonio, additional, Bertario, Lucio, additional, Chiappetta, Gennaro, additional, Gion, Massimo, additional, Tonini, Gian Paolo, additional, Podo, Franca, additional, Vocaturo, Amina, additional, Silvestrini, Rosella, additional, Lombardo, Claudio, additional, and Paradiso, Angelo, additional

Published
2010
Full Text
View/download PDF

38. The Integrated Oncology Program of the Italian Ministry of Health

Author

Paradiso, Angelo, primary, Mangia, Anita, additional, Orlando, Claudio, additional, Verderio, Paolo, additional, Belfiglio, Maurizio, additional, Marchetti, Antonio, additional, Bertario, Lucio, additional, Chiappetta, Gennaro, additional, Gion, Massimo, additional, Tonini, Gian Paolo, additional, Podo, Franca, additional, Vocaturo, Amina, additional, and Silvestrini, Rosella, additional

Published
2009
Full Text
View/download PDF

39. Developing Clinical Recommendations for Breast, Colorectal, and Lung Cancer Adjuvant Treatments Using the GRADE System: A Study From the Programma Ricerca e Innovazione Emilia Romagna Oncology Research Group

Author

De Palma, Rossana, primary, Liberati, Alessandro, additional, Ciccone, Giovannino, additional, Bandieri, Elena, additional, Belfiglio, Maurizio, additional, Ceccarelli, Manuela, additional, Leoni, Maurizio, additional, Longo, Giuseppe, additional, Magrini, Nicola, additional, Marangolo, Maurizio, additional, and Roila, Fausto, additional

Published
2008
Full Text
View/download PDF

40. Quality of diabetes care predicts the development of cardiovascular events: Results of the QuED study

Author

De Berardis, Giorgia, primary, Pellegrini, Fabio, additional, Franciosi, Monica, additional, Belfiglio, Maurizio, additional, Di Nardo, Barbara, additional, Greenfield, Sheldon, additional, Kaplan, Sherrie H., additional, Rossi, Maria C.E., additional, Sacco, Michele, additional, Tognoni, Gianni, additional, Valentini, Miriam, additional, and Nicolucci, Antonio, additional

Published
2008
Full Text
View/download PDF

42. Author reply

Author

Belfiglio, Maurizio, primary, Valentini, Miriam, additional, and Nicolucci, Antonio, additional

Published
2006
Full Text
View/download PDF

43. In Reply

Author

Nicolucci, Antonio, primary, Belfiglio, Maurizio, additional, Pellegrini, Fabio, additional, Sacco, Michele, additional, and Valentini, Miriam, additional

Published
2004
Full Text
View/download PDF

44. The impact of a pharmacist as a member of healthcare team on facilitating evidenced-based prescribing of innovative drugs in an Italian oncology department.

Author

Cioffi, Pasquale, Antonelli, Daniela, Belfiglio, Maurizio, Melena, Stefania, Petrelli, Fabio, and Grappasonni, Iolanda

Subjects
HEALTH care teams, PHARMACISTS, QUESTIONNAIRES, TUMORS, PHYSICIAN practice patterns, OFF-label use (Drugs), PHYSICIANS' attitudes, DESCRIPTIVE statistics
Abstract

Aims and background: At the Oncology Department of the Chieti and Ortona Hospitals, the pharmacist designated by the Abruzzo Region to oversee the obligatory monitoring of innovative oncological drugs listed in the database of the Italian Medicines Agency (AIFA) collaborates with oncologists to educate them about evidenced-based prescribing for off-label uses of drugs and to optimize the efficiency of spontaneous reporting of adverse drug reaction (ADR) local system.Methods: The contribution of the pharmacist as a member of the healthcare team was evaluated using the following indices: the percentage of off-label prescriptions of the innovative drugs monitored, the number of reported ADRs, and the percentage of pharmacist suggestions actually implemented by physicians.Results: In the course of 3 years (2008–2010), the pharmacist monitored a total of 843 patients treated with 716 appropriate uses and 127 off-label uses of drugs, oversaw a reduction in the latter from 28.3% in 2008 to 9.6% in 2010, and contributed to almost tripling the number of reported ADRs, from 10 in 2008 to 27 in 2010. In 2010, the pharmacist identified 60 potentially inappropriate prescribing cases, and proposed more appropriate prescriptions for each case: 68.3% (41) of the suggestions were implemented by the physicians and only 31.7% (19) were not. According to answers to a questionnaire administered at the end of the 2010 to evaluate the usefulness of this particular collaboration, physicians are interested in continuous and extensive collaboration.Conclusions: This article demonstrates that a pharmacist, active in the department as part of the heath-care team, can facilitate evidenced-based prescribing for off-label uses of drugs and improve spontaneous reporting of ADRs. [ABSTRACT FROM PUBLISHER]

Published
2012
Full Text
View/download PDF

45. Gemcitabine-induced posterior reversible encephalopathy syndrome: A case report.

Author

Cioffi, Pasquale, Laudadio, Lucio, Nuzzo, Antonio, Belfiglio, Maurizio, Petrelli, Fabio, and Grappasonni, Iolanda

Subjects
ANTIMETABOLITES, BLOOD testing, CEREBRAL anoxia, ELECTROCARDIOGRAPHY, MAGNETIC resonance imaging, PHYSICAL diagnosis, SOCIAL services case management, EARLY medical intervention, DISEASE risk factors
Abstract

Gemcitabine is a commonly used chemotherapeutic agent for a variety of tumors. Although this nucleoside analog antineoplastic agent is similar in structure to cytarabine, central nervous system toxicities have rarely been attributed to gemcitabine. The posterior reversible encephalopathy syndrome (PRES) is a condition characterized by reversible neurological and radiological findings that has been associated with use of chemotherapeutic and more recently novel targeted therapies. We describe one case of a 41-year-old woman with PRES under treatment for leiomyosarcoma because of the probable association with gemcitabine. Our case, to our knowledge, represents the seventh published report of this particular toxicity. Naranjo algorithm, efficacious method for assessing the causality of adverse drug reactions (ADRs) from a case report, suggests a direct casual relationship. PRES is probably a rare complication of gemcitabine, but the oncologist should take it into careful consideration, because PRES is reversible with treatment of current hypertension or removal of the causative agent. However, failure to quickly recognize the syndrome and discontinue the offending agent may result in profound and permanent central nervous system dysfunction or death. [ABSTRACT FROM PUBLISHER]

Published
2012
Full Text
View/download PDF

48. Research trends for early cancer biomarker detection in Italy: An Integrated Program in Oncology (PIO) survey

Author

Verderio, Paolo, Mangia, Anita, Orlando, Claudio, Belfiglio, Maurizio, Marchetti, Antonio, Bertario, Lucio, Chiappetta, Gennaro, Gion, Massimo, Tonini, Gian Paolo, Podo, Franca, Vocaturo, Amina, Silvestrini, Rosella, Lombardo, Claudio, Paradiso, Angelo, Pizzamiglio, Sara, Romani, Massimo, Belloni, Elena, Cavallo, Delia, Ulivi, Paola, Tommasi, Stefania, Steffan, Agostino, Russo, Antonio, Massimo, Alessio, Calistri, Daniele, Parrella, Paola, Broggini, Massimo, ANTONIO GIUSEPPE NACCARATO, Buttitta, Fiamma, Finocchiaro, Gaetano, Veronesi, Giulia, Landuzzi, Lorena, Benevolo, Maria, Mariani, Luciano, Marco, Federico, Venuti, Aldo, Giannelli, Gianluigi, Quaranta, Michele, and Trojano, Vito

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Biomedical Research, Early cancer, Neoplasms, Surveys and Questionnaires, Internal medicine, Cancer biomarker, Italy, Survey, Medicine (all), External quality assessment, Biomarkers, Tumor, medicine, Humans, Program Development, Early Detection of Cancer, Tumor marker, business.industry, Reproducibility of Results, General Medicine, Biological materials, Internal quality, Potential biomarkers, Critical Pathways, Biomarker (medicine), Christian ministry, business
Abstract

Aims and background In 2007, an Italian Research Network proposed to the Ministry of Health a concerted action aimed at developing a specific pathway for the analytical and clinical validation of new biomarkers for early cancer diagnosis. The action, funded by the Italian Ministry of Health within the Integrated Program in Oncology (PIO) and coordinated by the National Cancer Institute of Bari, started in 2008 involving 37 national research teams. Methods To monitor the methodological and analytical needs of the studies proposed by the research teams of PIO as well as to explore the plausibility of planning external quality assessment programs for early cancer biomarker detection, the coordinating team developed an ad hoc questionnaire that was submitted to each research team. Results From the collected data it emerged that about 70% of the biomarkers under investigation were analyzed according to nonroutine laboratory practices. The biological material utilized for biomarker assessment consisted of solid tissue (normal or pathological) in 31% of studies, serum in 21%, urine in 15%, plasma in 15%, and whole blood in 11%. Specific training of personnel directly involved in the program was reported by 18% of the teams. In 2008, only 6% of laboratories involved in PIO participated in both external quality assessment and internal quality control schemes specifically designed for the biomarkers under consideration. Standard operating procedures for the determination of about half (52%) of the biomarkers proved to be lacking in at least one phase of the biomarker assessment process. Conclusions On the basis of these results, we decided to give priority to the application of a four-phase process for the analytical validation of new potential biomarkers by setting up and applying standard operating procedures and developing external quality assessment and internal quality control schemes as specific steps of the workflow. Free full text available at www.tumorionline.it

Catalog

Books, media, physical & digital resources
See catalog results